Clin2
NCT07501039Likely a fitRecruiting

First test of BLKR201 in healthy adults

Healthy

This study tests a new medicine, called BLKR201, for the first time in people. It is given to healthy volunteers to see how safe it is and how the body handles it.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
128 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You are between 18 and 55 years old.
  • You are generally healthy with no major medical conditions.
  • You weigh at least 110 pounds (50 kilograms).
  • You are willing to stay at the research unit for the required visits.
  • You are willing to follow rules about diet, alcohol, tobacco, and medications.
  • You agree to use effective birth control (if applicable) and avoid pregnancy during the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07409922Recruiting· Phase 1
Testing KR23343 in healthy volunteers

This study tests a new medicine, KR23343, in healthy adults to see how the body handles it at different doses. It helps find the right dose and check for any early side effects.

Shanghai
NCT06745297Recruiting· Phase 1
Testing a new medicine in healthy men for safety

This study tests a new medicine (BI 3776528) in healthy men to see how well different doses are tolerated. It helps researchers find the safest dose before testing in people with a condition.

Berlin
NCT07235163Recruiting· Phase 1
Testing a new medicine in healthy adults

This study tests how a new medicine, PF-08065010, is handled by the body and how safe it is in healthy adults. It helps researchers find the right dose for future studies.

Brussels, Bruxelles-capitale, Région de
NCT07876076Not yet recruiting· Phase 1
Testing a new medicine for safety in healthy adults

This trial tests a new medicine called ADX-001 in healthy adults to see if it is safe, how the body handles it, and whether it triggers an immune response. It is an early-stage study, so it will help determine if the drug is safe enough for further testing in people with certain conditions.

NCT07412288Recruiting· Phase 1
Safety study of KT-579 in healthy volunteers

This trial tests the safety of a new drug called KT-579 in healthy adults. It is the first time this drug is being given to humans. The study will help doctors understand how the drug works in the body and if it is safe.

Lincoln, Nebraska
NCT07140055Not yet recruiting· Phase 1
Testing a new study drug in healthy adults

This study tests a new medicine called BLX-7006 in healthy adults to see if it is safe and to learn how the body handles it. Participating could help decide if the drug should be tested in people with certain conditions later.

Brisbane, Queensland

Hear when a new Healthy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.